低剂量阿司匹林对老年人的影响
1Department of Medicine, College of Medicine, Shaqra University, Shaqra, SAU.
Cureus
|March 25, 2024
概括
在老年人中,低剂量阿司匹林的使用被评估为预防心血管事件. 虽然有益,但潜在的出血风险需要仔细考虑,特别是对于糖尿病患者.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 阿司匹林是一种广泛使用的抗血小板药物,用于预防心血管事件和中风.
- 高剂量阿司匹林 (每天500毫克) 可能会降低长期结肠直肠癌的风险,但副作用可能会限制其有效性.
- 糖尿病患者患有心血管事件的风险较高,因此对阿司匹林在这一群体中的作用产生不确定性.
研究的目的:
- 评估低剂量阿司匹林在老年人中使用的影响和风险.
- 评估阿司匹林在特定人群中的益处 (心血管事件预防) 和风险 (出血) 之间的平衡.
- 审查目前对阿司匹林对结肠直肠癌和心血管健康的影响的理解.
主要方法:
- 对阿司匹林剂量,心血管事件,中风预防,结肠直肠癌和出血风险的研究进行文献综述.
- 对评估阿司匹林在老年人群和糖尿病患者中的疗效和安全性的研究进行分析.
- 评估阿司匹林使用,发病率和结直肠癌患者死亡率之间的关系.
主要成果:
- 低剂量阿司匹林用于预防心血管事件和中风.
- 虽然高剂量阿司匹林可能会降低结肠直肠癌的风险,但长期使用受到不良影响的限制.
- 阿司匹林使用降低了封闭性血管事件的风险,但增加了出血风险,特别是在老年人持续使用时.
结论:
- 低剂量阿司匹林对老年人心血管保护的好处需要仔细评估风险和益处.
- 对于糖尿病患者心血管预防的最佳阿司匹林使用仍然存在不确定性.
- 减少不适当的阿司匹林使用,特别是在老年人中,是非常重要的,因为长时间使用会增加出血风险.
相关概念视频
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
01:14Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:29Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K